Pfizer, Rowan pursue solvent recovery

Pfizer (NYSE:PFE) has teamed with Rowan University to develop green manufacturing techniques. The focus is solvents--often the primary waste component in API production.

The collaborators are investigating the economic and environmental impacts of solvent recovery and reuse in small-volume waste streams, as opposed to incineration. Solvent recovery is already used in large-scale operations, but existing techniques don't lend themselves to small-scale operations.

The Rowan team designed a system for isopropanol solvent recovery from the manufacture of nelfinavir, the active ingredient in the antiretroviral drug Viracept. Researchers also evaluated the system for use with other of Pfizer's small-volume waste streams from multi-product facilities.

Computer-based life-cycle assessment for three drugs showed CO2 emission reductions of 677,000 kg per year.

- read the article


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.